Tag
Sriven Pharmachem India Private Limited
2 articles
Astal Labs Q2 FY2026 Net Profit at ₹379 Lakhs
Astal Laboratories board approved unaudited standalone and consolidated financial results for Q2 and H1 FY2026 ending September 30, 2026.
Standalone Q2 revenue reached ₹4,087.75 lakhs with net profit
Astal Labs Q2 Net Profit Rises to ₹379 Lakhs
Board approved unaudited standalone and consolidated financial results for Q2 and H1 FY27, ending September 30, 2026.
Standalone Q2 revenue grew 8.9% YoY to ₹4,087.75 lakhs, with net profit at ₹379.12